MK2206 treatment suppressed p-AKT (p < 0.001) and PD98059 treatment suppressed p-ERK (p < 0.001) in RA CD4+ T cells, irrespective of JKAP knockdown (Figures 4A–4C). This evidence concerns the gene AKT1 and rheumatoid arthritis.